Dyne TherapeuticsDYN

那斯達克 · USD
18.06
-1.93
(-9.65%)
收盤 03/13 03:59 (UTC+8)
03/13 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
營業收入淨額
-
-
-
-
-
-
-
-
-
-
營業成本
----------
營業毛利
-
-
-
-
-
-
-
-
-
-
營業費用
116,129113,892115,791-----67,68862,274
研發費用
95,43197,21999,236106,44781,80592,79962,26344,53958,84455,251
推銷及管理費用
20,69816,67316,55515,92515,30312,8609,69924,6188,8447,023
非經常性項目費用
----------
其他營業費用
----------
營業利益
-116,129
-113,892
-115,791
-122,372
-97,108
-105,659
-71,962
-69,157
-67,688
-62,274
其他收入及費用
7,3688,7565,0277,0117,5668,5346,8603,5081,0502,064
利息費用
3,1942,90494-------
稅前純益
-111,955
-108,040
-110,858
-115,361
-89,542
-97,125
-65,102
-65,649
-66,638
-60,210
所得稅
----------
稅後純益
-111,955
-108,040
-110,858
-115,361
-89,542
-97,125
-65,102
-65,649
-66,638
-60,210
基本每股稅後盈餘(元)
-0.76-0.76-0.97-1.05-0.88-0.96-0.70-0.81--0.99
稀釋每股稅後盈餘(元)
-0.73-0.72-0.97-1.05-0.88-0.98-0.70-0.81-1.09-0.98
基本平均股數(千股)
147618.00141810.00113873.00109911.00101982.00100882.0092507.0081043.00-61109.00
稀釋平均股數(千股)
147618.00141810.00113873.00109911.00101982.00100882.0092507.0081043.00-61109.00
還原基本每股稅後盈餘(元)
-0.76-0.76-0.97-1.05-0.88-0.96-0.70-0.81--0.99
還原稀釋每股稅後盈餘(元)
-0.73-0.72-0.97-1.05-0.88-0.98-0.70-0.81-1.09-0.98
還原基本平均股數(千股)
147,618141,810113,873109,911101,982100,88292,50781,043-61,109
還原稀釋平均股數(千股)
147,618141,810113,873109,911101,982100,88292,50781,043-61,109
EBITDA(千元)
-108,628-104,981-110,724-115,475-89,928-97,663-65,972-65,786-66,433-60,144

大家都在看

HOT